# Fivos

> Fivos provides cloud-based clinical registry infrastructure, registry management, and real-world evidence services for medical societies and medical device manufacturers. Its PATHWAYS platform supports specialty outcomes tracking, while its Device Evaluation Portal and custom data services help manufacturers evaluate device performance. Following the sale of its workflow products, the company focuses on registries and evidence generation.

- **Founded:** 2006
- **Headquarters:** West Lebanon, United States
- **Founders:** Wael Elseaidy (Co-founder and former CEO of predecessor Medstreaming), Ewald de Vries (Co-founder and former CTO of predecessor Medstreaming)
- **Products:** PATHWAYS, Device Evaluation Portal (DEP), Society registry management, Medical-device data services
- **Notable:** PATHWAYS supports the SVS Vascular Quality Initiative., Current Fivos society materials report 1,000+ participating centers and 1.4 million-plus procedures for the VQI success story., A 2020 six-study analysis found estimated savings from reuse of VQI infrastructure; M2S performed study operations.

## Products & services

- **PATHWAYS** — Cloud-based clinical registry platform for structured procedural data, follow-up, validation, reporting, and benchmarking.
- **Device Evaluation Portal (DEP)** — Tiered subscription access to device usage, patient characteristics, outcomes, and blinded peer benchmarking from clinical registries; launched in late 2024.
- **Society registry management** — Registry design and implementation, operations, contracting, customer support, marketing, and accounting services.
- **Medical-device data services** — Custom analysis, external control arms, pre- and post-market study support, regulatory submission support, and long-term surveillance.

## Achievements

- PATHWAYS supports the SVS Vascular Quality Initiative.
- Current Fivos society materials report 1,000+ participating centers and 1.4 million-plus procedures for the VQI success story.
- A 2020 six-study analysis found estimated savings from reuse of VQI infrastructure; M2S performed study operations.

## Latest updates

- **—** — An undated Fivos product interview published after Will Israel joined in spring 2026 describes DEP enhancements, including one-year outcomes and blinded peer benchmarking.
- **2025-12** — Carta Healthcare announced a partnership with Fivos for AI-assisted clinical abstraction with clinical experts.

## Links

- Website: https://fivoshealth.com/
- LinkedIn: https://www.linkedin.com/company/fivoshealth
- Twitter/X: https://twitter.com/M2S_Inc
- Facebook: https://facebook.com/M2Sinc

---

Profile page: https://yespress.io/fivos
Published by YesPress — https://yespress.io
Last updated: 2026-10-23